Press Releases

Burns brings nearly two decades of experience in cardiovascular imaging, echocardiography education and clinical program leadership.

The newly cleared platform provides cardiac care teams with a continuous, consolidated view of hemodynamic and organ function status.

European Heart Journal publication of PIONEER IV data confirms QFR-guided PCI matches conventional strategies while reducing procedural complexity.

The acquisition deepens Integration Health's perfusion staffing capabilities through Perfusion Life's nationwide network.

Register today for the premier collaboration of interventional cardiovascular care providers in the Southwest United States.

Significant improvements in heart wall thickness, heart function and quality of life, as well as an excellent safety profile, were reported in an interim analysis of the BioVAT-HF clinical trial.

Exstent has appointed Matt Thompson its chief executive officer to lead the company’s next stage of global growth and expand access to its personalized external aortic support technology.

Tolpegin brings more than two decades of leadership experience with nonprofit medical organizations, including her role as the CEO of the Society of Cardiovascular Computed Tomography.

Data strongly support the technology for effective, efficient and safe probe placement versus blind intubation in TEE procedures.

Naples Comprehensive Health (NCH) announced that Joseph Lamelas, MD, an internationally renowned cardiothoracic surgeon and pioneer in minimally invasive cardiac surgery, will join the NCH Rooney Heart Institute in Naples on Oct. 15.

Integration Health announces the acquisition of ECMO Advantage, combining the industry's two leading ECMO service providers to create the definitive national platform for ECMO program development, specialized staffing, transport and education services.

Biome Analytics is set to launch the Biome Virtual Analyst — a groundbreaking AI-powered tool that gives hospitals immediate answers to complex performance, clinical, and financial questions without sifting through dashboards or reports.

New company structure enhances service delivery while preserving Innovative ECMO Concepts’ brand recognition.

The decision follows a request for reexamination by Egg Medical, which argued the patent covered technology that had already been invented.

Biome Analytics has launched Biome IMPACT, a new AI-enabled methodology to support cardiovascular performance improvement. The framework helps health systems identify opportunities, align stakeholders and track measurable results—without adding to the team’s workload.

Breakthrough autologous solution aims to provide lifelong durability for young heart patients.

Biome Analytics is proud to welcome Javier Valle, MD—renowned interventional cardiologist and national quality leader—as our new chief medical officer. His deep clinical expertise and commitment to high-value care will help shape the future of cardiovascular performance improvement.

Hospitals can now measure and improve outcomes through the lens of social and economic disparities by integrating social determinants of health (SDOH) directly into their performance analytics.

Special T MRI, an independent, state-of-the-art imaging center located in Fenton, Missouri, is proud to announce the launch of its advanced cardiac MRI imaging program aimed at enhancing early detection and management of heart disease through non-invasive cardiac MRI technology.

NASA is constantly working toward enhancing astronaut safety through the development of next-generation spacesuits. In collaboration with the German medical technology developer Corscience, a crucial milestone has been achieved in advancing the design and functionality of spacesuits for the upcoming Artemis lunar missions.

This achievement highlights Positron's commitment to providing innovative imaging solutions that enable healthcare providers to elevate patient care and achieve superior clinical outcomes.

This partnership underscores Peak Heart & Vascular’s dedication to improving patient outcomes through research, education and the latest medical technologies, ensuring they remain at the forefront of cardiovascular care in Arizona.

Following its recent $43 million Series B funding, the company is expanding its data integration capabilities to include a broader range of devices, including wearables, heart failure monitoring, and remote patient monitoring.

The procedure was performed in Greenville, North Carolina.

Congratulations to Stanford Medicine on winning the 2023 Hearst Health Prize for its artificial intelligence solution that helps identify patients at risk for heart attack by scoring incidental coronary artery calcium (CAC) on non-gated chest CTs.

Predictive model generation for pre-planning a cardiac procedure now reimbursable by Medicare at approximately $1,000 per model

Late-Breaking Science sessions reveal revolutionary findings on severe aortic stenosis and mild-to-severe mitral regurgitation identification through innovative AI technology.

The company's multifaceted healthcare staffing solutions play a pivotal role in transforming patient care and elevating industry standards.

The agreement formally endorses Corazon’s cardiovascular accreditation.

Arineta Cardio Imaging is excited to announce the FDA 510(k) clearance of the SpotLight and SpotLight Duo family of cardiovascular CT scanners.

Researchers and engineers at Mayo Clinic and Ultromics developed technology that can detect HFpEF using a single A4C echocardiogram clip, to help clinicians detect a complex form of heart failure easily and accurately. 

The Midwest company will begin offering EchoSolv, an artificial intelligence clinical decision support platform designed to help detect severe aortic stenosis, to providers throughout the country.

Precision TAVI is the first FDA-approved predictive modeling tool for medical teams planning TAVR procedures.

RecoverRite’s Online Heart Learning Center to feature ACC’s CardioSmart patient tools and resources.

PulseAI, a leader in the development of cutting-edge AI-powered ECG software, has released the results of a clinical study that has shown the superiority of its deep learning AI over the Apple Watch ECG algorithm in the detection of atrial fibrillation.

NAPLES, Fla. – February 20, 2023   The NCH Healthcare System is proud to announce a $20 million naming gift from the Rooney Foundation, which is the philanthropic arm of the former U.S. Representative for Florida's 19th congressional district and his wife, Francis and Kathleen Rooney.  In recognition of increasing their $8 million pledge announced last July, the entire cardiac program across NCH Healthcare System will be renamed “The Rooney Heart Institute.”

NAPLES, Fla. – February 21, 2023   On the heels of our historic $20 Million gift announcement made last week, NCH is proud to announce yet a second $20 million naming gift in as many weeks from Diana and Don Wingard.  This generous gift will provide the necessary funds to ensure that the NCH Stroke program continues to provide the highest level of care and treatment to patients in Southwest Florida.  Additionally, in recognition of the extraordinary pledge, the entire stroke program across NCH will be renamed the “Wingard Stroke Institute.”

When using this service, patients have the ability to upload and share data without limitations. From radiology CDs to PDFs or JPG files, patients can use their smartphone connected to the Patient Image Exchange app and upload images, share lab results, immunizations records, nurses’ notes, dental images and much more.

Ancora Heart has hired senior financial leader David J. Tucker as its chief financial officer. This is the company's second C-suite hire in 2022, following the addition of Mark Miles as chief commercial officer in June.

Geneticure, a global leader in the genetic variability of response to hypertension treatments, presented data at the 2022 American Heart Association Scientific Sessions meeting from a recent clinical study in which they were able to successfully predict patients who will respond to renal denervation (RDN). In addition, the Geneticure test for renal denervation also identified patients with an increase in blood pressure, following the procedure.

Long-awaited milestone gives physicians and their patients greater access to prescription cardiac arrhythmia detection solutions, including the company’s Cardea SOLO™ ECG System